7. Список использованной литературы:

1)        Обзор нового коронавируса 2019 года (2019-nCoV), CDC, 1 февраля 2020 г.Источник контента: Национальный центр иммунизации и респираторных заболеваний (NCIRD), Отдел вирусных заболеваний; https://www.cdc.gov/coronavirus/2019-nCoV/summary.html

2)        Hui, David S.; Azhar, Esam EI; Madani, Tariq A.; Ntoumi, Francine; Kock, Richard; Dar, Osman; Ippolito, Giuseppe; Mchugh, Timothy D.; Memish, Ziad A. The continuing epidemic threat of novel coronaviruses to global health – the latest novel coronavirus outbreak in Wuhan, China (англ.) // International Journal of Infectious Diseases: journal. — 2020. — 14 January (vol. 91). — P. 264—266. — ISSN 1201-9712. — DOI:10.1016/j.ijid.2020.01.009.

3) Тромбо-воспалительный синдром при COVID-19. Место и роль антикоагулянтной терапии в лечении COVID-19/Сугралиев А.Б., Plinio Cirillo//Ж.Медицина (Алматы)-№3 (213) 2020 г.]

4) Undiagnosed pneumonia – China (HU) (01): wildlife sales, market closed, RFI Archive Number: 20200102.6866757. Pro MED mail. International Society for Infectious Diseases. Датаобращения 13 января 2020.

5)        Guidance COVID-19: investigation and initial clinical management of possible cases/ https://www.gov.uk/government/publications/ Updated 27 April 2020.

6) ZhonghuaJie, He He, Hu Xi, ZaZhi. Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing. Article in Chinese; Abstract available in Chinese from the publisher.

7)        Jonas F Ludvigsson. Systematic review of COVID-19 in children show milder cases and a better prognosis than adults. Actapediatrica. First published:23 March 2020   https://doi.org/10.1111/apa.15270.

8)        Laboratory testing for 2019 novel coronavirus  (2019-nCoV) in suspected human cases    Interim guidance  17 January 2020.

9) Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 7 (03.06.2020г) МЗ РФ, с.165.

10) Методические рекомендации «Особенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (COVID-19) у детей, версия 2 – 03.07.2020г., с.4-8.

11) «Updated diagnosis, treatment and prevention of COVID-19 in children: experts’ consensus statement condensed version of the second edition», Kun-Ling Shen, Yong-Hong Yang, […] – Global Pediatric Pulmonology Alliance,  World Journal of Pediatrics volume 16, pages232–239 (2020).

12) Global Surveillance for human infection with novel coronavirus (2019-nCoV) Interim guidance, 27 February 2020

13) Coronavirus disease 2019 (COVID-19): Epidemiology, virology, clinical features, diagnosis, and prevention. Mar 2020, lastupdated: Apr 30, 2020/https://www.uptodate.com/

14) Клиническое ведение тяжелой острой респираторной инфекции при подозрении на коронавирусную инфекцию COVID-19: Временные рекомендации 13 марта 2020 г. – ВОЗ.

15)  RussellFM, ReyburnR, ChanJ, TuivagaE, LimR, LaiJetal.Impact of the change in WHO’s severe pneumonia case definition on hospitalized pneumonia epidemiology: case studies from six countries. Bull World Health Organ. 2019;97(6):386-93. Epub 2019/06/19. doi: 10.2471/BLT.18.223271. PubMedPMID: 31210676; PMCID: PMC6560369.

16) ВОЗ «Оказание стационарной помощи детям: руководство по ведению наиболее распространенных болезней детского возраста. Женева: Всемирная организация здравоохранения; 2013 г. (http://www.who.int/maternal_child_adolescent/documents/child_hospital_care/en/, accessed 4 March 2020).

17) Coronavirus Infections in Children Including COVID-19. An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children/Zimmermann, Petra; Curtis, Nigel //The Pediatric Infectious Disease Journal: May 2020 – Volume 39 – Issue 5 – p 355-368.

18) Morven S Edwards, MDSectionEditor:Sheldon L Kaplan, MDDeputyEditor:Mary M Torchia, MD. Coronavirus disease 2019 (COVID-19): Considerations in children/Literature review current through: Mar 2020. | This topic last updated: Uptodate, Apr 10, 2020.

20) КПДЛ «Слизисто-кожный лимфонодулярный синдром Кавасаки у детей», 29 сентября 2016 года, протокол №11 МЗ РК.

21) Laboratory testing for 2019 novel coronavirus  (2019-nCoV) in suspected human cases    Interim guidance  17 January 2020.

22) Bernheim A, Mei X, Huang M et al (2020) Chest CT findings in coronavirus Disease-19 (COVID-19): relationship to duration of infection. Radiology. https://doi.org/10.1148/radiol.2020200463

23) Liu H, Liu F, Li J, Zhang T, et al. Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children. J Infect. 2020 Mar 20. pii: S0163-4453(20)30118-3. СанПиН 2.6.1.1192-03

24) Mathur S, PillenahalliMaheshwarappa R, Fouladirad S, Metwally O, et al. Emergency Imaging in Pregnancy and Lactation. Can AssocRadiol J. 2020 Mar 11:846537120906482.

25) Poon, LC, Yang H, Lee JC, et al. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. UltrasoundObstetGynecol. 2020.doi: 10.1002/uog.22013.

26) Временные алгоритмы по ведению пациентов с инфекцией, вызванной SARS-CoV-2 в клиниках Военно-медицинской академии. Версия 3.0 (8.07.2020 г.). Санкт-Петербург 2020.С37.

27) Консенсусное заявление РАСУДМ об ультразвуковом исследовании легких в условиях COVID-19 (версия 1)/ Митьков В.В. соавт // Ультразвуковая и функциональная диагностика. 2020. № 1. С. 24–45. DOI: 10.24835/1607-0771-2020-1-24-45.

28) WHO. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected   Interim guidance January 2020, updated on 19 March 2020. https://www.who.int/publications-detail/global-surveillance-for-human-infection-with-novel-coronavirus-(2019-ncov).  

29) Horby P, Lim WS, Emberson J, and the, RECOVERY Collaborative Group. Effect of dexamethasone in hospitalized patients with COVID-19: Preliminary report. medRxiv. 2020 Jun 22.

30) European Medicines Agency. EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19. March 2020. ([Internet].Available from:): https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19

31) Coronavirus disease 2019 (covid-19). BMJ Best practice 2020. Last updated 20 May 2020: https://bestpractice.bmj.com/topics/en-gb/3000168

32) Приказ Министра здравоохранения Республики Казахстан от 8 января 2018 года № 2 «О внесении изменения в приказ Министра здравоохранения Республики Казахстан от 3 июля 2017 года № 450 «Об утверждении Правил оказания скорой медицинской помощи в Республике Казахстан»;

33)      Приказ Министерства здравоохранения РК от 20.11.2019 № ҚР ДСМ-144 «Об утверждении Стандарта организации оказания медицинской помощи при инфекционных заболеваниях в Республике Казахстан»;

34)      Приказ и.о. Министра здравоохранения Республики Казахстан от 27 марта 2018 года № 126 «Об утверждении Санитарных правил «Санитарно-эпидемиологические требования к организации и проведению санитарно-противоэпидемических, санитарно-профилактических мероприятий по предупреждению инфекционных заболеваний».

35) Прасмыцкий О. Т., Ржеутская Р. Е. Интенсивная терапия заболеваний, сопровождающихся острой дыхательной недостаточностью. – 2008. https://www.twirpx.com/file/2409878

36) Beigel JH, Tomashek KM, Dodd LE et al, Remdesivir for the Treatment of Covid-19 – Preliminary Report. N Engl J Med. 2020

37)      КП «Грипп и ОРВИ». Одобрен Объединенной комиссией по качеству медицинских услуг Министерства здравоохранения Республики Казахстан от «19» апреля 2019 года Протокол №63

38) Du B., Qiu HB., Zhan X. et al. Pharmacotherapeutics for the New Coronavirus Pneumonia. Article in Chinese; Abstract available in Chinese from the publisher; https://www.ncbi.nlm.nih.gov/pubmed/32057209

39) Clinical outcomes among hospital patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Abdulrahman Mohammed G. Habib, Mohamed AbdElghafour Ali., Baha R., Zouaoui. at. al. https://dx.doi.org/10.1186%2Fs12879-019-4555-5. ww.ncbi.nlm.nih.gov/pmc/articles/PMC6805532/

40) Jin YH., Cai L., Cheng ZS. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Jin et al. Military Medical Research (2020) 7:4. https://www.ncbi.nlm.nih.gov/pubmed/32029004.

41)  Zhou F., Yu T., Du R., Fan G. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet Published Online First: 11 March 2020. doi:10.1016/S0140-6736(20)30566-3

42) Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma Chenguang Shen, at all //JAMA. Published online March 27, 2020. doi:10.1001/jama.2020.4783

43) https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments

44) Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019nCoV lung injury. Lancet. 2020 Feb 15;395(10223):473-5.  DOI: 10.1016/S0140-6736(20)30317-2

45) Chen D, Yang H, Cao Y, et al. Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection. Int J Gynaecol Obstet. 2020 Mar 20 doi: 10.1002/ijgo.13146.

46) Cao B, Wang Y, Wen D, et al. A trial of lopinavir–ritonavir in adults hospitalized with severe COVID-19. N Engl J Med. 2020 Mar 18 DOI: 10.1056/NEJMoa2001282

47). Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID19: results of an open‐label non‐randomized clinical trial. Int J Antimicrob Agents. 2020 Mar 17 doi: 10.1016/j.ijantimicag.2020.105949.

48) COVID-19 Prevention and Treatment Handbook. The first clinical hospital. Faculty of Medicine, Zhejiang University. The reference is based on clinical data and experience  edited by Tingbo LIANG at al. March 2020 Zhejiang University School of Medicine. https://www.researchgate.net/publication/339998871_Handbook_of_COVID-19_Prevention_and_Treatment

49) Interim clinical guidance for patients suspected of/confirmed with COVID-19 in Belgium. 19 March 2020; Version 4. http://www.med.umich.edu/asp/pdf/adult_guidelines/COVID-19-treatment.pdf

50). Inpatient guidance for treatment of COVID-19 in adults and children.  Michigan Medicine University of M Michigan.11 March  2020 http://www.med.umich.edu/asp/pdf/adult_guidelines/COVID-19-treatment.pdf

51) Ritesh M.  Evidence Summary Clinical Management of COVID-19. King’s Critical Care 9th March 2020. NHS Health Education England https://nwpgmd.nhs.uk/Specialty_Schools/Surgery/COVID-19

52) Coronavirus Disease Guide 2019Prevention, control, diagnosis and treatment.  Edited by: The State Health Commission (GKZ) of the PRC State Administration for Traditional Chinese Medicine of the PRC Translation: Association of Chinese Professional Professionals. Issuing translators: Siaofeng LIANG, Zhiyan FENG, Leaming LI. 2020 ISBN 978-7-117-29817-9.

53) Adarsh B., Morgan R L., Shumakeat A H. al Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection. 11 April 2020 https://www.idsociety.org/COVID19guidelines

54) Guidelines for the treatment of people with COVI-19 disease Edition 2.0, 13 March 2020 Italian Society of Infectious and Tropical Diseases. https://www.acep.org/globalassets/images/italian-guidelines-for-covid-19-google-translate.pdf.pdf

55) https://www.medrxiv.org/content/10.1101/2020.06.

56) Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. WHO/2019-nCoV/Clinical/2020.4  ([Internet].Available from:): https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected

57) Lynora Saxinger, Nelson Lee, John Conly, John Gill Recommendations for Antimicrobial Management of Adult Hospitalized Patients with COVID-19. Alberta Health Services. ([Internet]. Available from:):  https://pubs.acs.org/doi/10.1021/acscentsci.0c00272.

58) Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands/MatthijsOudkerk et all//Published Online:Apr 23 2020https://doi.org/10.1148/radiol.2020201629

59) ISTH interim guidance on recognition and management of coagulopathy in COVID‐19/JeckoThachil, et all// First published:25 March 2020 https://doi.org/10.1111/jth.14810

60) Goren A, Vaño‐Galván S, Wambier CG, et al. J Cosmet Dermatol. 2020 Apr 16. doi: 10.1111/jocd.13443. Spironolactone in Covid-19 Induced ARDS. https://clinicaltrials.gov/ct2/show/NCT04345887

61) Коронавирусная болезнь COVID-19: неиспользованные возможности терапии.   Регулярные выпуски «РМЖ» №9 от 26.06.2020 стр. 1-5.                Авторы: Громов А.А. 1, 2 , Кручинина М.В. 1 , Рабко А.В. 1, 3 Новосибирск

62) Hui, David S.; Azhar, Esam EI; Madani, Tariq A.; Ntoumi, Francine; Kock, Richard; Dar, Osman; Ippolito, Giuseppe; Mchugh, Timothy D.; Memish, Ziad A. The continuing epidemic threat of novel coronaviruses to global health – the latest novel coronavirus outbreak in Wuhan, China (англ.) // International Journal of Infectious Diseases: journal. — 2020. — 14 January (vol. 91). — P. 264—266. — ISSN 1201-9712. — DOI:10.1016/j.ijid.2020.01.009.

63) Руководство по лечению COVID-19. Updated 21/04/2020 https://www.covid19treatmentguidelines.nih.gov

64) International Pulmonologist’s consensus on COVID-19/March 2020//www.researchgate.net/publication/340666754_International_Pulmonologist’s_consensus_on_COVID-19

65) ) COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. Accessed [insert date].

80)  clinicaltrials.gov (NCT04395105)

66) Horby P, Lim WS, Emberson J, and the, RECOVERY Collaborative Group. Effect of dexamethasone in hospitalized patients with COVID-19: Preliminary report. medRxiv. 2020 Jun 22.

https://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1.full.pdf

67) Early Short Course Corticosteroids in Hospitalized Patients with COVID-19 https://www.medrxiv.org/content/10.1101/2020.05.04.20074609v1

67) https://pubmed.ncbi.nlm.nih.gov/32167524/

68) Early Short Course Corticosteroids in Hospitalized Patients with COVID-19 https://www.medrxiv.org/content/10.1101/2020.05.04.20074609v1

69) https://www.recoverytrial.net/results/hydroxychloroquine-results

70) Qingxian CaiMinghui YangDongjing Liu et al. Experimental Treatment With Favipiravir for COVID-19: An Open-Label Control Study, Engineering 2020

71) Peter Horby, Wei Shen Lim,  Jonathan Emberson et al, Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report https://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1

72) Yeming WangDingyu Zhang,Guanhua Du et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial, Lancet. 2020 16-22 May; 395(10236): 1569–1578

73) Протокол лечения критических состояний COVID-19. EVMS Medical group (Пол Марик, отделение легочной и критической медицины Медицинского института Восточной  Вирджинии, Норфолк, Вирджиния, 11 мая2020г.). С 14. Providence, R.I. J Am Acad Dermatol. 2020 Apr 10. doi: 10.1016/j.jaad.2020.04.032.

74) Favre G, Pomar L, Qi X, et al. Guidelines for pregnant women with suspected SARS-CoV-2 infection. Lancet Infect Dis. 2020 Mar 3 [Epub ahead of print].

75)  Technical Report. Novel coronavirus (SARS-CoV-2).Discharge criteria for confirmed COVID-19 cases –When is it safe to discharge COVID-19 cases from the hospital or end home isolation?/European Centre for disease prevention and control// www.ecdc.europa.eu 76) Руководство по профилактике и лечению новой коронавирусной инфекции COVID-19. Первая академическая клиника Университетской школы медицины провинции Чжэцзян. Составлено на основе клинической практики. 2020. С96

Алмаз Шарман, Президент Академии профилактической медицины
Казахстан, 050008, г. Алматы, ул. Клочкова 66, офис 601
+7 (727) 317-8855
academypm@outlook.com